ImmunoHorizons

438 papers and 3.7k indexed citations i.

About

The 438 papers published in ImmunoHorizons in the last decades have received a total of 3.7k indexed citations. Papers published in ImmunoHorizons usually cover Immunology (303 papers), Molecular Biology (94 papers) and Epidemiology (72 papers) specifically the topics of Immune Cell Function and Interaction (170 papers), T-cell and B-cell Immunology (122 papers) and Immune Response and Inflammation (55 papers). The most active scholars publishing in ImmunoHorizons are David J. Dowling, Lauren A. Zenewicz, Thirumala‐Devi Kanneganti, Rajendra Karki, R. K. Subbarao Malireddi, Geeta K. Swamy, Genevieve G. Fouda, David R. Martinez, Sallie R. Permar and Sannula Kesavardhana.

In The Last Decade

Fields of papers published in ImmunoHorizons

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers published in ImmunoHorizons. Nodes represent fields, and links connect fields that are likely to share authors.

Countries where authors publish in ImmunoHorizons

Since Specialization
Total citations of papers

This map shows the geographic distribution of research published in ImmunoHorizons. It shows the number of citations received by papers published by authors working in each country. You can also color the map by specialization and compare the number of papers published in ImmunoHorizons with the expected number of papers based on a country's size and research output (numbers larger than one mean the country's share of papers is larger than expected).

Rankless by CCL
2025